Cancer cells also activate stromal fibroblasts, enabling them to become cancer-associated fibroblasts (CAFs), at least in part by secreting molecules (e.g., tumour growth factor-beta [TGF-β]) that invoke phenotypic changes such as myofibroblastic differentiation and senescence [14–16]. The gene discussed is TGFB1; the disease is cancer.